Role of nonsteroidal anti-inflammatory drugs in gastrointestinal tract injury and repair

Journal of the American Veterinary Medical Association

Volumn 222, Issue 7, 2003, Pages 946-951

  Tomlinson, Julia ^a   Blikslager, Anthony ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

DIGESTIVE SYSTEM INJURY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FATTY ACID METABOLISM; GASTROINTESTINAL MUCOSA; MUCOSA INFLAMMATION; NEUTROPHIL; NONHUMAN; PROSTAGLANDIN SYNTHESIS; REVIEW; STOMACH ACID;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DIGESTIVE SYSTEM; GASTROINTESTINAL DISEASES; PROSTAGLANDINS; WOUND HEALING;

EID: 0037377824     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2003.222.946     Document Type: Review

References (70)

1. Soll A. Pathogenesis of nonsteroidal anti-inflammatory drug-related toxicity. Am J Med 1998;105:10S-15S.
2. Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000;119:521-535.
3. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999;340:1888-1899.
4. Zushi S, Shinomura Y, Tatsuya K, et al. Role of prostaglandins in intestinal epithelial restitution stimulated by growth factors. Am J Physiol 1996;270:G757-G762.
5. Levi S, Goodlad RA, Lee CY, et al. Inhibitory effect of nonsteroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990;336:840-43.
6. Olivero JJ, Graham DY. Gastric adaptation to nonsteroidal anti-inflammatory drugs in man. Scand J Gastroenterol 1992;27:53-58.
7. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231:232-235.
8. Rossat J, Mailard M, Nussberger J, et al. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 1999;66:76-84.
9. Schoen RT, Vender RJ. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med 1989;86:449-458.
10. Davenport HW. Gastric mucosal injury by fatty acid and acetylsalicylic acids. Gastroenterology 1964;93:245-253.
11. Jorgensen TG, Weis-Fogh US, Nielsen HH, et al. Salicylate and aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach. Scand J Clin Lab Invest 1976;36:649-654.
12. Roediger WEW, Mollard S. Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis? Gut 1995;36:55-59.
13. Yamanda T, Deitch E, Specian RD, et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993;17:641-662.
14. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-263.
15. Wallace JL, Bell CJ. Gastromucosal defense. Curr Opin Gastroenterol 1996;12:503-511.
16. Whittle BJR. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile salts, and the actions of prostaglandins. Br J Pharmacol 1977;60:455-460.
17. Wolfe MM, Soll AH. The physiology of gastric acid secretion. N Engl J Med 1988;319:1707-1715.
18. Whittle BJR, Espulugues JV. Induction of rat gastric damage by the endothelium-derived peptide, endothelin. Br J Pharmacol 1988;95:1033-1101.
19. 2 metabolism. Gut 1992;33:164-169.
20. Lipscomb GR, Wallis N, Armstrong G, et al. Gastric mucosal adaptation to etodolac and naproxen. Aliment Pharmacol Ther 1995;9:379-385.
21. Taha AS, Angerson W, Nakshabendi I, et al. Gastric and duodenal mucosal blood flow in patients receiving nonsteroidal anti-inflammatory drugs, influence of age, smoking, ulceration and Helicobacter pylori. Aliment Pharmacol Ther 1993;7:41-45.
22. Ruh J, Schmidt E, Vogel F, et al. Indomethacin-induced disturbances in villous microcirculation in the rat ileum. Microvasc Res 1999;58:137-143.
23. El-Bayer H, Steel L, Montcalm E, et al. The role of endogenous prostaglandins in the regulation of gastric secretion in rhesus monkeys. Prostaglandins 1985;30:401-417.
24. Soll AH. Mechanisms of action of antisecretory drugs. Scand J Gastroenterol 1986;21(125):1-6.
25. Appleyard CB, McCafferty DM, Tigley AW, et al. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol 1996;270:G42-G48.
26. Wallace JL, McKnight W, Miyasaka M, et al. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol 1993;265:G993-G998.
27. Yamagiwa S, Yoshida Y, Halder RC, et al. Mechanisms involved in enteropathy induced by administration of nonsteroidal anti-inflammatory drugs (NSAIDS). Dig Dis Sci 2001;1:192-199.
28. Nygard G, Anthony A, Piasecki C, et al. Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology 1994;106:567-575.
29. Vaananen PM, Meddings JB, Wallace JL. Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol 1991;261:G470-G475.
30. Wallace JL, Granger DN. Pathogenesis of NSAID gastropathy: are neutrophils the culprits? Trends Pharmacol Sci 1992;13:129-131.
31. Beck PL, Xavier R, Lu N, et al. Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology 2000;119:699-705.
32. Asako H, Hubes P, Wallace J, et al. Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am J Physiol 1992;262:G903-G908.
33. Day JP, Lanas A, Rustagi P, et al. Reversible prolonged skin bleeding time in acute gastrointestinal bleeding presumed due to NSAIDs. J Clin Gastroenterol 1996;22:96-103.
34. Hawkey CJ, Hawthorne AB, Hudson N, et al. Separation of aspirin's impairment of hemostasis from mucosal injury in the human stomach. Clin Sci 1991;81:565-573.
35. Jenkins AP, Trew DR, Crump BJ, et al. Do nonsteroidal anti-inflammatory drugs increase colonic permeability? Gut 1991;32:66-69.
36. Evans JM, McMahon AD, Murray FE, et al. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997;40:619-622.
37. Stamm C, Burkhalter CE, Pearce W, et al. Benign colonic ulcers associated with nonsteroidal anti-inflammatory drug ingestion. Am J Gastroenterol 1994;89:2230-2233.
38. Blikslager AT, Zimmel DN, Young KM, et al. Recovery of ischemic-injured porcine ileum: evidence for a contributory role of COX-1 and COX-2. Gut 2002;50:615-623.
39. Dieckgraefe BK, Stenson WF, Alpers DH. Gastrointestinal epithelial response to injury. Curr Opin Gastroenterol 1996;12:109-114.
40. Podolsky DK. Mucosal immunity and inflammation V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am J Physiol 1999;227:G495-G499.
41. 2 induces villous contraction in rats without affecting intestinal restitution. Gastroenterology 1990;99:708-716.
42. 2 have a synergistic role in rescuing epithelial barrier function in porcine ileum. J Clin Invest 1997;100:1928-1933.
43. Hull MA, Brough JL, Hawkey CJ. Expression of cyclooxygenase-1 and 2 by human gastric endothelial cells. Gut 1999;45:529-536.
44. Tomisato W, Tsutsumi S, Rokutan K, et al. NSAIDs induce both necrosis and apoptosis in guinea pig gastric mucosal cells in primary culture. Am J Physiol 2001;281:G1092-G1100.
45. Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Ranitidine in the treatment of nonsteroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991;32:252-255.
46. Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989;320:69-75.
47. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988;2:1277-1280.
48. Lanza FL, Aspinall RL, Swabb EA, et al. Double-blind, placebo-controlled endoscopic comparison of the protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988;95:289-294.
49. Fu JY, Masferrer JL, Seibert K, et al. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990;265:16737-16740.
50. Masferrer JL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci U S A 1994;91:3228-3232.
51. Hawkey CJ. COX-2 inhibitors. Lancet 1999;353:307-314.
52. Riendeau D, Charleson S, Cromlish W, et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal antiinflammatory drugs and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 1997;75:1088-1095.
53. Wolfe MM. Future trends in the development of safer nonsteroidal anti-inflammatory drugs. Am J Med 1998;105(suppl 5A):44S-52S.
54. Sawaoka H, Tsuji S, Tsuji M, et al. Expression of the cyclooxygenase-2 gene in gastric epithelium. J Clin Gastroenerol 1997;25(suppl 1):S105-S110.
55. Mizuno H, Sakamoto C, Matsunda K, et al. Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997;112:387-397.
56. Reuter BK, Asfaha S, Buret A, et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 1996;98:2076-2085.
57. 2 is an early anti-inflammatory signal in experimental colitis. Am J Physiol 2000;279:G238-G244.
58. Vogiagis D, Glare EM, Misajon A, et al. Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach, effects of aging and ulcers. Am J Physiol 2000;278:G820-G827.
59. Wallace JL, McKnight W, Reuter B, et al. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase-1 and 2. Gastroenterology 2000;119:706-714.
60. Wallace JL, Bak A, McKnight W, et al. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 1998;115:101-109.
61. Muscara MN, McKnight W, Asfaha S, et al. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br J Pharmacol 2000;129:681-686.
62. Sigthorsson G, Jacob M, Wrigglesworth S, et al. Comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat. Scand J Gastroenterol 1998;33:728-735.
63. Kirtikara K, Morham SG, Raghow R, et al. Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells. J Exp Med 1998;187:517-523.
64. Langenbach R, Morham SG, Tiano HF, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin induced gastric ulceration. Cell 1995;83:483-492.
65. Dinchuk JE, Car BD, Focht RJ, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase 11. Nature 1995;378:406-409.
66. Wallace JL, Miller MJS. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 2000;119:512-520.
67. Fischer H, Becker JC, Boknik P, et al. Expression of endothelial cell-derived nitric oxide synthase (eNOS) is increased during gastric adaptation to chronic aspirin intake in humans. Aliment Pharmacol Ther 1999;13:507-514.
68. Ma L, Wallace JL. Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. Am J Physiol 2000;279:G341-G346.
69. Elliot SN, McKnight W, Cirino G, et al. A nitric oxide releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995;109:524-530.
70. Lichtenberger LM, Wang ZM, Romero JJ, et al. Nonsteroidal anti-inflammatory drugs associate with zwitteronic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med 1995;1:154-158.